1. Home
  2. ASIX vs CGEM Comparison

ASIX vs CGEM Comparison

Compare ASIX & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdvanSix Inc.

ASIX

AdvanSix Inc.

HOLD

Current Price

$15.84

Market Cap

526.1M

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$10.66

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASIX
CGEM
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
526.1M
671.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ASIX
CGEM
Price
$15.84
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$32.00
$27.14
AVG Volume (30 Days)
478.8K
1.3M
Earning Date
11-07-2025
11-06-2025
Dividend Yield
4.00%
N/A
EPS Growth
35.47
N/A
EPS
1.92
N/A
Revenue
$1,491,348,000.00
N/A
Revenue This Year
$4.71
N/A
Revenue Next Year
$4.59
N/A
P/E Ratio
$8.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.10
$5.68
52 Week High
$32.73
$13.60

Technical Indicators

Market Signals
Indicator
ASIX
CGEM
Relative Strength Index (RSI) 45.72 58.77
Support Level $15.05 $10.01
Resistance Level $16.00 $13.33
Average True Range (ATR) 0.53 1.07
MACD 0.26 -0.00
Stochastic Oscillator 89.43 47.06

Price Performance

Historical Comparison
ASIX
CGEM

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: